177 related articles for article (PubMed ID: 38596681)
1. Induction of islet autoimmunity to defective ribosomal product of the insulin gene as neoantigen after anti-cancer immunotherapy leading to autoimmune diabetes.
van Tienhoven R; Jansen DTSL; Park M; Williams JC; Larkin J; Quezada SA; Roep BO
Front Immunol; 2024; 15():1384406. PubMed ID: 38596681
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic correlates of islet-autoimmune signatures in juvenile-onset type 1 diabetes.
Claessens LA; Wesselius J; van Lummel M; Laban S; Mulder F; Mul D; Nikolic T; Aanstoot HJ; Koeleman BPC; Roep BO
Diabetologia; 2020 Feb; 63(2):351-361. PubMed ID: 31754749
[TBL] [Abstract][Full Text] [Related]
3. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
4. Human islet T cells are highly reactive to preproinsulin in type 1 diabetes.
Anderson AM; Landry LG; Alkanani AA; Pyle L; Powers AC; Atkinson MA; Mathews CE; Roep BO; Michels AW; Nakayama M
Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34611019
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
Durinovic-Belló I
Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes.
Kracht MJ; van Lummel M; Nikolic T; Joosten AM; Laban S; van der Slik AR; van Veelen PA; Carlotti F; de Koning EJ; Hoeben RC; Zaldumbide A; Roep BO
Nat Med; 2017 Apr; 23(4):501-507. PubMed ID: 28263308
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading.
Prasad S; Kohm AP; McMahon JS; Luo X; Miller SD
J Autoimmun; 2012 Dec; 39(4):347-53. PubMed ID: 22647732
[TBL] [Abstract][Full Text] [Related]
9. IFNɣ but not IFNα increases recognition of insulin defective ribosomal product-derived antigen to amplify islet autoimmunity.
Thomaidou S; Munoz Garcia A; de Lange S; Gan J; van der Slik AR; Hoeben RC; Roep BO; Carlotti F; Zaldumbide A
Diabetologia; 2023 Nov; 66(11):2075-2086. PubMed ID: 37581620
[TBL] [Abstract][Full Text] [Related]
10. Beta-cell markers and autoantigen expression by a human insulinoma cell line: similarities to native beta cells.
Cavallo MG; Dotta F; Monetini L; Dionisi S; Previti M; Valente L; Toto A; Di Mario U; Pozzilli P
J Endocrinol; 1996 Jul; 150(1):113-20. PubMed ID: 8708552
[TBL] [Abstract][Full Text] [Related]
11. Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells.
van Tienhoven R; Kracht MJL; van der Slik AR; Thomaidou S; Wolters AHG; Giepmans BNG; Riojas JPR; Nelson MS; Carlotti F; de Koning EJP; Hoeben RC; Zaldumbide A; Roep BO
Diabetologia; 2023 May; 66(5):884-896. PubMed ID: 36884057
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic duodenal homeobox 1 protein is a novel beta-cell-specific autoantigen for type I diabetes.
Li SW; Koya V; Li Y; Donelan W; Lin P; Reeves WH; Yang LJ
Lab Invest; 2010 Jan; 90(1):31-9. PubMed ID: 19901909
[TBL] [Abstract][Full Text] [Related]
13. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
[TBL] [Abstract][Full Text] [Related]
14. B7-H4 expression in normal and diseased human islet β cells.
Cheung SS; Ou D; Metzger DL; Meloche M; Ao Z; Ng SS; Owen D; Warnock GL
Pancreas; 2014 Jan; 43(1):128-34. PubMed ID: 24326367
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune responses to the beta cell autoantigen, insulin, and the INS VNTR-IDDM2 locus.
Sarugeri E; Dozio N; Belloni C; Meschi F; Pastore MR; Bonifacio E
Clin Exp Immunol; 1998 Dec; 114(3):370-6. PubMed ID: 9844045
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.
Coppieters KT; Dotta F; Amirian N; Campbell PD; Kay TW; Atkinson MA; Roep BO; von Herrath MG
J Exp Med; 2012 Jan; 209(1):51-60. PubMed ID: 22213807
[TBL] [Abstract][Full Text] [Related]
17. Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen.
Diez J; Park Y; Zeller M; Brown D; Garza D; Ricordi C; Hutton J; Eisenbarth GS; Pugliese A
Diabetes; 2001 Apr; 50(4):895-900. PubMed ID: 11289059
[TBL] [Abstract][Full Text] [Related]
18. Autoimmunity against INS-IGF2 protein expressed in human pancreatic islets.
Kanatsuna N; Taneera J; Vaziri-Sani F; Wierup N; Larsson HE; Delli A; Skärstrand H; Balhuizen A; Bennet H; Steiner DF; Törn C; Fex M; Lernmark Å
J Biol Chem; 2013 Oct; 288(40):29013-23. PubMed ID: 23935095
[TBL] [Abstract][Full Text] [Related]
19. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens.
Honeyman MC; Stone NL; Falk BA; Nepom G; Harrison LC
J Immunol; 2010 Feb; 184(4):2204-10. PubMed ID: 20083660
[TBL] [Abstract][Full Text] [Related]
20. Genetic and therapeutic control of diabetogenic CD8+ T cells.
Santamaria P
Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
